Indegene sees tailwinds in the US, expanding in Europe
Bengaluru-based life sciences commercialisation firm Indegene sees significant headroom for growth in the US, its largest market, despite uncertainties around the new Trump regime’s stance on regulatory and pricing issues. Top global pharma companies are doubling down on the use of technology and AI to make processes more agile, which plays to Indegene’s strengths, CEO … Read more